5-ARIs for Benign Prostatic Hyperplasia Can Lead to Delayed Prostate Cancer Diagnosis

Researchers looked at the use and effects of 5 α-reductase inhibitors to treat benign prostatic hyperplasia on prostate cancer outcomes.

Source: CancerNetwork - May 8, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news